Dear reader of, please excuse the disruption. needs about $63500 in 2024. In 2023 we received donations of about $ 32200. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2024 would be over after a few days. This donation request is displayed 23,000 times a week, but only 75 people donate. If you find useful, please take a minute and support with your donation. Thank you!

Since 01.06.2021 is supported by the non-profit ADxS e.V..

$26199 of $63500 - as of 2024-06-30
Header Image
Reboxitin for ADHD


Reboxitin for ADHD

Reboxitine is a noradrenaline reuptake inhibitor, as well as a weak serotonin reuptake inhibitor.

Trade names: Edronax (D, CH, A), Solcenx (D)

The active ingredient reboxitine is a noradrenergic drug which, according to individual reports, can be effective for ADHD. As an antidepressant, as it was actually intended to be, it was probably quite unsuccessful.

The updated European consensus on the diagnosis and treatment of ADHD (2018) names reboxitine as a possible alternative to atomoxetine for ADHD.1

There is evidence that reboxitine is effective for ADHD. However, there are only a few controlled studies and reboxitine could be used primarily in adults without comorbidities.23

In Germany, Reboxitin is not reimbursed by health insurance companies.